XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Private Placement Two
Series A Preferred Stock
Series B Preferred Stock
Preferred stock
Series A Preferred Stock
Preferred stock
Series B Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023 435,120.513                  
Beginning balance at Dec. 31, 2023 $ 296,851                  
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Issuance of Series A Preferred Stock in connection with private placement and settlement of related forward contract (in shares)   99,140.326                
Issuance of Series A Preferred Stock in connection with private placement and settlement of related forward contract   $ 75,197                
Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity (in shares) (534,260.839)                  
Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity $ (372,048)                  
Ending balance (in shares) at Mar. 31, 2024 0                  
Ending balance at Mar. 31, 2024 $ 0                  
Beginning balance at Dec. 31, 2023 3,703                  
Increase (Decrease) In Temporary Equity, Option, Roll Forward [Roll Forward]                    
Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity (3,703)                  
Ending balance at Mar. 31, 2024 0                  
Preferred stock, beginning balance (in shares) at Dec. 31, 2023         0 0        
Beginning balance at Dec. 31, 2023 (440,184)       $ 0 $ 0 $ 1 $ 179,062 $ (614,647) $ (4,600)
Common stock, beginning balance (in shares) at Dec. 31, 2023             5,397,597      
Increase (Decrease) in Stockholders' Equity                    
Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity (in shares)         534,260.839          
Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity 375,751             375,751    
Issuance of common stock upon exercise of options (in shares)             52,558      
Issuance of common stock upon exercise of options 154             154    
Issuance of common stock upon exercise of warrants (in shares)             65,681      
Issuance of common stock upon exercise of warrants 2,877             2,877    
Stock-based compensation expense 1,431             1,431    
Currency translation adjustment (5)                 (5)
Net income (loss) (56,824)               (56,824)  
Preferred stock, ending balance (in shares) at Mar. 31, 2024         534,260.839 0        
Ending balance at Mar. 31, 2024 $ (116,800)       $ 0 $ 0 $ 1 559,275 (671,471) (4,605)
Common stock, ending balance (in shares) at Mar. 31, 2024             5,515,836      
Beginning balance (in shares) at Dec. 31, 2023 435,120.513                  
Beginning balance at Dec. 31, 2023 $ 296,851                  
Ending balance (in shares) at Jun. 30, 2024 0                  
Ending balance at Jun. 30, 2024 $ 0                  
Beginning balance at Dec. 31, 2023 3,703                  
Ending balance at Jun. 30, 2024 0                  
Preferred stock, beginning balance (in shares) at Dec. 31, 2023         0 0        
Beginning balance at Dec. 31, 2023 (440,184)       $ 0 $ 0 $ 1 179,062 (614,647) (4,600)
Common stock, beginning balance (in shares) at Dec. 31, 2023             5,397,597      
Increase (Decrease) in Stockholders' Equity                    
Currency translation adjustment 9                  
Net income (loss) (42,988)                  
Preferred stock, ending balance (in shares) at Jun. 30, 2024         166,341.592 0        
Ending balance at Jun. 30, 2024 $ (101,458)       $ 0 $ 0 $ 2 560,766 (657,635) (4,591)
Common stock, ending balance (in shares) at Jun. 30, 2024             17,816,238      
Beginning balance (in shares) at Mar. 31, 2024 0                  
Beginning balance at Mar. 31, 2024 $ 0                  
Ending balance (in shares) at Jun. 30, 2024 0                  
Ending balance at Jun. 30, 2024 $ 0                  
Beginning balance at Mar. 31, 2024 0                  
Ending balance at Jun. 30, 2024 0                  
Preferred stock, beginning balance (in shares) at Mar. 31, 2024         534,260.839 0        
Beginning balance at Mar. 31, 2024 (116,800)       $ 0 $ 0 $ 1 559,275 (671,471) (4,605)
Common stock, beginning balance (in shares) at Mar. 31, 2024             5,515,836      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             36,451      
Issuance of common stock upon exercise of options 120             120    
Equity offering costs (219)             (219)    
Conversion of Series A Preferred Stock to common stock (in shares)         (367,919.247)   12,263,951      
Conversion of Series A Preferred Stock to common stock 0           $ 1 (1)    
Stock-based compensation expense 1,591             1,591    
Currency translation adjustment 14                 14
Net income (loss) 13,836               13,836  
Preferred stock, ending balance (in shares) at Jun. 30, 2024         166,341.592 0        
Ending balance at Jun. 30, 2024 $ (101,458)       $ 0 $ 0 $ 2 560,766 (657,635) (4,591)
Common stock, ending balance (in shares) at Jun. 30, 2024             17,816,238      
Preferred stock, beginning balance (in shares) at Dec. 31, 2024 0   120,790.402 437,927 120,790.402 437,927        
Beginning balance at Dec. 31, 2024 $ (6,802)       $ 0 $ 0 $ 3 689,887 (692,071) (4,621)
Common stock, beginning balance (in shares) at Dec. 31, 2024 25,767,369           25,767,369      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             55,690      
Issuance of common stock upon exercise of options $ 183             183    
Issuance of vested restricted stock units (in shares)             113,042      
Stock-based compensation expense 2,508             2,508    
Currency translation adjustment 32                 32
Net income (loss) (17,710)               (17,710)  
Preferred stock, ending balance (in shares) at Mar. 31, 2025         120,790.402 437,927        
Ending balance at Mar. 31, 2025 $ (21,789)       $ 0 $ 0 $ 3 692,578 (709,781) (4,589)
Common stock, ending balance (in shares) at Mar. 31, 2025             25,936,101      
Preferred stock, beginning balance (in shares) at Dec. 31, 2024 0   120,790.402 437,927 120,790.402 437,927        
Beginning balance at Dec. 31, 2024 $ (6,802)       $ 0 $ 0 $ 3 689,887 (692,071) (4,621)
Common stock, beginning balance (in shares) at Dec. 31, 2024 25,767,369           25,767,369      
Increase (Decrease) in Stockholders' Equity                    
Currency translation adjustment $ 44                  
Net income (loss) $ (1,824)                  
Preferred stock, ending balance (in shares) at Jun. 30, 2025 0   120,790.402 437,927 120,790.402 437,927        
Ending balance at Jun. 30, 2025 $ (2,527)       $ 0 $ 0 $ 3 695,942 (693,895) (4,577)
Common stock, ending balance (in shares) at Jun. 30, 2025 26,000,065           26,000,065      
Preferred stock, beginning balance (in shares) at Mar. 31, 2025         120,790.402 437,927        
Beginning balance at Mar. 31, 2025 $ (21,789)       $ 0 $ 0 $ 3 692,578 (709,781) (4,589)
Common stock, beginning balance (in shares) at Mar. 31, 2025             25,936,101      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             25,690      
Issuance of common stock upon exercise of options 85             85    
Issuance of vested restricted stock units (in shares)             38,274      
Stock-based compensation expense 3,279             3,279    
Currency translation adjustment 12                 12
Net income (loss) $ 15,886               15,886  
Preferred stock, ending balance (in shares) at Jun. 30, 2025 0   120,790.402 437,927 120,790.402 437,927        
Ending balance at Jun. 30, 2025 $ (2,527)       $ 0 $ 0 $ 3 $ 695,942 $ (693,895) $ (4,577)
Common stock, ending balance (in shares) at Jun. 30, 2025 26,000,065           26,000,065